Explore ›
Finding
Finding
improvement
Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neuropathy score from time 1 to time 2.
| Effect size | OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction) |
| Follow-up | 21 days |
| Comparator | Placebo (L-glycine), identical in texture, aroma, and taste, for 21 days |
| Effect summary | improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction) |
Connected entities
Interventions
Outcomes
Populations
Source
PMC5598352
Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer